Prostaglandin E Synthesis and Release by Murine Macrophages and Human Monocytes After in Vitro Treatment with Biological Response Modifiers
- 1 January 1983
- journal article
- research article
- Published by Taylor & Francis in Journal of Immunopharmacology
- Vol. 5 (3) , 129-146
- https://doi.org/10.3109/08923978309039102
Abstract
Prostaglandins of the E series (PGE), produced by mononuclear phagocytes, have many biological activities and are involved in the regulation of myelopoiesis and of the cytotoxic activities of macrophage (M+) and natural killer (NK) cells. Since one of the possible effects of biological response modifiers (BRMs) on immune regulation might be modulation of PGE production, resident peritoneal murine M+ (mMψ) and elutriated human blood mono-cytes (hM) were incubated with BRMs and the supernatants were then assayed for PGE. Control mMψ produced about 4.9 ng PGE/105 mMψ over a 24 hr period. Lipopolysaccharide (LPS, 1-5 μg/ml), polyinosinic-polycytidylic acid complexed with poly-L-lysine (Poly ICLC, 0.1-10 μg/ml) and murine α,β-interferon, (IFN, 10-1000 μ/ml) all caused a highly significant increase in PGE-secretion. BM41.332, a 2–cyanoaziridine (25-50 μg/ml), was found to be less stimulatory, whereas the pyran copolymer MVE-2 (25-50 μg/ml), and Azimexone (25–50 μg/ml) had marginal effects on PGE-production. Kinetic studies showed that the plateau of PGE-production by mMψ occurred during the first 24 hr of incubation, and mMψ which were washed after a 24 hr incubation period could not be restimulated to produce more PGE. PGE release by hM was increased after stimulation with LPS, Poly ICLC and BM41.332, whereas human IFNs (α and β) induced a slight decrease in PGE production. As in the murine studies, Azimexone and MVE-2 had no detectable effect. The ability of some BRMs to augment PGE-secretion by mMψ and hM may contribute to their negative effects on host responses, such as suppression of NK cell activity.This publication has 27 references indexed in Scilit:
- Effects of prostaglandins on the development of cell-mediated immunity in culture and on the cytolytic activity of in vivo-generated effector cellsInternational Journal of Immunopharmacology, 1982
- Human Blood Monocytes: Characterization of Negatively Selected Human Monocytes and Their Suspension Cell Culture DerivativesScandinavian Journal of Immunology, 1981
- The effect of prostaglandin metabolism on immunoglobulin and antibody production in naive and educated whole spleen cellsProstaglandins and Medicine, 1981
- Prostaglandin inhibition of T-cell proliferation is mediated at two levelsCellular Immunology, 1981
- Immune response modifying activity in mice of polyinosinic: Polycytidylic acid stabilized with poly-L-lysine, in carboxymethylcellulose [Poly-ICLC]International Journal of Immunopharmacology, 1981
- Reversible inhibition by interferon of the maturation of human peripheral blood monocytes to macrophagesCellular Immunology, 1980
- Prostaglandin generation by human and guinea pig lung tissue: Comparison of parenchymal and airway responsesJournal of Allergy and Clinical Immunology, 1979
- Regulation of macrophage and granulocyte proliferation. Specificities of prostaglandin E and lactoferrinThe Journal of Experimental Medicine, 1979
- A possible role of prostaglandins in the inhibition of natural and antibody-dependent cell-mediated cytotoxicity against tumor cellsCellular Immunology, 1978
- Prostaglandin E production by human blood monocytes and mouse peritoneal macrophages.The Journal of Experimental Medicine, 1978